Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to learn if 3D-printed heart models and augmented reality can be useful modalities to teach medical students about congenital heart disease. The main questions it aims to answer are:
Participants will:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Slide-based lecture | Other | Participants in this group received teaching using a slide-based lecture |
|
| 3D-printed Model | Active Comparator | This group received teaching using 3D-printed models |
|
| Augmented Reality | Active Comparator | This group received teaching using augmented reality headsets |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| 3D-printed heart models and augmented reality | Other | Participants will receive an educational session regarding congenital heart disease using a slide-based lecture, 3D-printed models, or augmented reality headsets. |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in Pre and Post-test Scores | Participants completed a 16-item, multiple choice questionnaire about the anatomy and physiology of the normal heart and two complex congenital heart defects. The questionnaire is broken down into 4 questions on basic cardiology and 6 questions each pertaining specifically to tetralogy of Fallot and hypoplastic left heart syndrome. The questionnaire is delivered pre-intervention, immediately post-intervention, and again at 3-weeks post intervention. Correct answers are scored as true (1) and incorrect answers scored as false (0) with a score range of 0-16 with higher scores indicating better retention and understanding of the curriculum. | Enrollment Pre-Intervention, Baseline Post-Intervention, and 3 Weeks Post-Intervention |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Arpit Agarwal, MD | University Hospitals Cleveland Medical Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Case Western Reserve University School of Medicine | Cleveland | Ohio | 44106 | United States |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot | Yes | No | No | Study Protocol | Oct 10, 2024 | Dec 19, 2025 | Prot_000.pdf |
Not provided
| ID | Term |
|---|---|
| D013771 | Tetralogy of Fallot |
| D018636 | Hypoplastic Left Heart Syndrome |
| ID | Term |
|---|---|
| D006330 | Heart Defects, Congenital |
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| D000013 | Congenital Abnormalities |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |